135 related articles for article (PubMed ID: 3515764)
41. Superficial keratitis.
Maudgal PC; Missotten L
Bull Soc Belge Ophtalmol; 1980; 187(1):1-192. PubMed ID: 6970603
[No Abstract] [Full Text] [Related]
42. [Pathomorphological study of antiviral chemotherapeutic effectiveness of bonaphthon under experimental conditions].
Nikolaeva IS; Kutchak SN; Bogdanova NS; Pershin GN
Farmakol Toksikol; 1976; 39(3):336-41. PubMed ID: 1026519
[TBL] [Abstract][Full Text] [Related]
43. [Combined herpetic lesions of the oral mucosa and skin in children].
Mikhaĭlovskaia VP; Bintsarovskaia GV
Stomatologiia (Mosk); 1981; 60(6):11-3. PubMed ID: 6947549
[No Abstract] [Full Text] [Related]
44. Recurrent herpes in the rabbit and man.
Kaufman HE; Brown DC; Ellison EM
Science; 1967 Jun; 156(3782):1628-9. PubMed ID: 4290539
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy for herpes simplex virus infections.
Erlich KS; Mills J
West J Med; 1985 Nov; 143(5):648-55. PubMed ID: 3909643
[No Abstract] [Full Text] [Related]
46. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
Rajcáni J; Reefschläger J
Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
[TBL] [Abstract][Full Text] [Related]
47. Changes in the vaginal cytology of the guinea pig induced by herpes simplex virus.
Lucia HL; Mayo DR; Hsiung GD
Acta Cytol; 1983; 27(3):365-70. PubMed ID: 6223477
[TBL] [Abstract][Full Text] [Related]
48. [Treatment of experimental herpetic keratitis in rabbits with acycloguanosine (author's transl)].
Colin J; Fily J; Renard G; Chastel C
Pathol Biol (Paris); 1981 Jan; 29(1):43-5. PubMed ID: 7010275
[TBL] [Abstract][Full Text] [Related]
49. [Antiherpetic activity of Soviet-made phosphonic acid derivatives and their combinations with interferon inducers in a model of ophthalmic herpes].
L'vov ND; Samoĭlovich EO; Tikhonchuk IA; Chepaĭkina TA; Tsvetkov EN
Vopr Virusol; 1989; 34(2):186-92. PubMed ID: 2527446
[TBL] [Abstract][Full Text] [Related]
50. An improved system for the evaluation of antiviral compounds against herpes simplex virus type 2.
Yin S; Li Y; Xia H; Zhao J; Zhang Z; Tang S; Kou Z; Chen J; Yu J; Fan Z; Li T
J Virol Methods; 2013 May; 189(2):317-20. PubMed ID: 23454799
[TBL] [Abstract][Full Text] [Related]
51. [Experimental herpetic infection of the CNS with predominant involvement of the spinal cord].
Kolomiets AG; Votiakov VI; Duboĭskaia GP; Kolomiets ND; Poleshchuk NN
Vopr Virusol; 1991; 36(1):44-8. PubMed ID: 1858355
[TBL] [Abstract][Full Text] [Related]
52. [The efficacy of an antiviral factor obtained from infected chick embryo fibroblasts in an experimental herpetic infection].
Gribkova NV; Andreeva OT; Votiakov VI; Khmara ME
Vopr Virusol; 1994; 39(4):182-4. PubMed ID: 7998399
[TBL] [Abstract][Full Text] [Related]
53. Antiviral activity of Win 41258-3, a pyrazole compound, against herpes simplex virus in mouse genital infection and in guinea pig skin infection.
Pancic F; Steinberg BA; Diana GD; Carabateas PM; Gorman WG; Came PE
Antimicrob Agents Chemother; 1981 Mar; 19(3):470-6. PubMed ID: 7247370
[TBL] [Abstract][Full Text] [Related]
54. [Effect of riodoxol on herpes simplex virus morphogenesis in experimental eye infection].
Stebaeva LF; Nikolaeva IS; Pershin GN
Vopr Virusol; 1982; (1):90-4. PubMed ID: 6280397
[TBL] [Abstract][Full Text] [Related]
55. Herpes simplex keratitis: animal models to guide the selection and optimal delivery of antiviral chemotherapy.
Falcon MG; Jones BR
J Antimicrob Chemother; 1977 Mar; 3 Suppl A():83-9. PubMed ID: 863807
[No Abstract] [Full Text] [Related]
56. Effect of 2'-fluoro-5-methyl-ara-uracil and cyclophosphamide on herpes simplex virus infection in guinea pigs.
Zheng ZM; Landry ML; Mayo DR; Hsiung GD
Zhongguo Yao Li Xue Bao; 1987 Mar; 8(2):158-63. PubMed ID: 2959004
[No Abstract] [Full Text] [Related]
57. Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals.
Sidwell RW; Allen LB; Khare GP; Huffman JH; Witkowski JT; Simon LN; Robins RK
Antimicrob Agents Chemother; 1973 Feb; 3(2):242-6. PubMed ID: 4790589
[TBL] [Abstract][Full Text] [Related]
58. Cutaneous herpes simplex virus infection of guinea pigs as a model for antiviral chemotherapy.
Schafer TW; Lieberman M; Everitt J; Came P
Ann N Y Acad Sci; 1977 Mar; 284():624-31. PubMed ID: 280151
[TBL] [Abstract][Full Text] [Related]
59. [The combined treatment of experimental genital herpes with preparations of interferon and acycloguanosine administered systemically and locally].
Mel'nikov VR; Kobrinskiĭ GD; Lidak MIu; Barinskiĭ IF
Vopr Virusol; 1993; 38(2):69-71. PubMed ID: 8059524
[TBL] [Abstract][Full Text] [Related]
60. Genital herpes: pathogenesis and chemotherapy in the guinea pig model.
Hsiung GD; Mayo DR; Lucia HL; Landry ML
Rev Infect Dis; 1984; 6(1):33-50. PubMed ID: 6324317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
